User profiles for Bequet-Romero M
Monica BequetOther name: Monica Bequet-Romero Senior Researcher, Cancer Immunotherapy, Biomedical Research, CIGB, CUBA Verified email at cigb.edu.cu Cited by 1193 |
Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
O López-Ocejo, A Viloria-Petit, M Bequet-Romero… - Oncogene, 2000 - nature.com
Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with
high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular …
high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular …
[HTML][HTML] An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
…, D Gonzalez-Roche, M Bequet-Romero… - New …, 2022 - Elsevier
… m/zcalc correspond to the calculated m/z values for all tryptic peptides generated by the in-…
m/zexp correspond to the experimental m/z values for all tryptic peptides observed in the ESI…
m/zexp correspond to the experimental m/z values for all tryptic peptides observed in the ESI…
[HTML][HTML] CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
…, R Peña-Ruiz, M Bequet-Romero… - Cell Stress and …, 2021 - Elsevier
Hyperinflammation distinguishes COVID-19 patients who develop a slight disease or none,
from those progressing to severe and critical conditions. CIGB-258 is a therapeutic option for …
from those progressing to severe and critical conditions. CIGB-258 is a therapeutic option for …
Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins
M Bequet-Romero, O López-Ocejo - Biochemical and Biophysical …, 2000 - Elsevier
Altered angiogenesis response is observed in patients with cervical cancer. In this study we
examined whether Human Papilloma Virus (HPV) positive epithelial cells are able to …
examined whether Human Papilloma Virus (HPV) positive epithelial cells are able to …
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds
…, M Béquet‐Romero… - International Wound …, 2019 - Wiley Online Library
Diabetic foot ulcer is one of the most frightened diabetic complications leading to amputation
disability and early mortality. Diabetic wounds exhibit a complex networking of inflammatory …
disability and early mortality. Diabetic wounds exhibit a complex networking of inflammatory …
Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
…, J De La Torre, Y Morera-Díaz, M Bequet-Romero… - Vaccine, 2014 - Elsevier
CIGB-247 is a novel cancer therapeutic vaccine that uses a human VEGF variant molecule
as antigen, in combination with a bacterial adjuvant. In mice, CIGB-247 has anti-tumor and …
as antigen, in combination with a bacterial adjuvant. In mice, CIGB-247 has anti-tumor and …
Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants
Y Morera, M Bequet-Romero, M Ayala, H Lamdán… - Angiogenesis, 2008 - Springer
Following the clinical success of Bevacizumab, a humanized monoclonal antibody that
affects the interaction between vascular endothelial growth factor (VEGF) and its receptors, …
affects the interaction between vascular endothelial growth factor (VEGF) and its receptors, …
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
Y Morera, M Bequet-Romero, M Ayala, JC Velazco… - Vaccine, 2010 - Elsevier
We have developed a cancer vaccine candidate (hereafter denominated CIGB-247), based
on recombinant modified human vascular endothelial growth factor (VEGF) as antigen, and …
on recombinant modified human vascular endothelial growth factor (VEGF) as antigen, and …
Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine
Y Morera, J Sánchez, M Bequet-Romero… - Vaccine, 2017 - Elsevier
CIGB-247 is a cancer therapeutic vaccine, based on recombinant modified human vascular
endothelial growth factor (VEGF) as antigen, in combination with the adjuvant VSSP, a …
endothelial growth factor (VEGF) as antigen, in combination with the adjuvant VSSP, a …
[HTML][HTML] Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis
…, A Díaz, Y González, M Bequet-Romero… - Archives of …, 2023 - Springer
There is an urgent need to understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-host
interactions involved in virus spread and pathogenesis, which might …
interactions involved in virus spread and pathogenesis, which might …